10-15 Associates’s Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) VST.WS.A Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$6K Hold
10,194
﹤0.01% 93
2020
Q2
$6K Hold
10,194
﹤0.01% 97
2020
Q1
$8K Sell
10,194
-546
-5% -$760 ﹤0.01% 92
2019
Q4
$23K Hold
10,740
﹤0.01% 101
2019
Q3
$22K Hold
10,740
﹤0.01% 98
2019
Q2
$21K Hold
10,740
﹤0.01% 99
2019
Q1
$23K Hold
10,740
﹤0.01% 98
2018
Q4
$15K Hold
10,740
﹤0.01% 92
2018
Q3
$16K Sell
10,740
-303
-3% -$391 ﹤0.01% 101
2018
Q2
$13K Buy
+11,043
New +$10K ﹤0.01% 109

Other funds holding VST.WS.A

10-15 Associates's VST.WS.A Position: Q3 2020 in Review

10-15 Associates held its Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) (VST.WS.A) position steady in Q3 2020 at 10,194 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #93.

10-15 Associates first reported a position in VST.WS.A in Q2 2018 and has held it in 10 quarters since. The position peaked at $23K in Q4 2019. 20 funds tracked by Wall St. Rank hold VST.WS.A as of Q3 2020.

  • 10-15 Associates held 10,194 shares of Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) worth $6K as of Q3 2020.
  • 10-15 Associates left its Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) share count unchanged in Q3 2020.
  • Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) made up ﹤0.01% of 10-15 Associates's portfolio in Q3 2020, its #93 holding.
  • 10-15 Associates first reported a position in Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) in Q2 2018 and has held it in 10 quarters since.
  • 10-15 Associates's Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) position peaked at $23K in Q4 2019.
  • 20 funds tracked by Wall St. Rank held Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024) as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.